Journal of Advanced Pharmaceutical Technology amp Research · 2016 · 14 citations · 16 references
MedicinePediatricsPsychiatryChild PsychiatryPediatric Mental HealthPsychopharmacologyAttention-deficit/hyperactivity DisorderNeurodevelopmental DisordersPediatric Clinical TrialsPediatric PsychopharmacologyPsychopharmacology In ChildrenStimulant TherapyAdhd TreatmentAdverse Treatment EffectsChildhood AdhdMedication Adverse EffectsMethylphenidate TherapyPediatric Stimulant MedicationsPediatric Stimulant TreatmentSingle-blind Trials
= 0.002). The most common adverse effects were anorexia (21.7%) and daytime drowsiness (17.4%) in combination treatment group and insomnia (33.3%) and anorexia (25%) in methylphenidate group. Risperidone and methylphenidate may be effective and well tolerated in preschool children with ADHD, and adding risperidone to methylphenidate may decrease the occurrence of some side effects of methylphenidate such as insomnia and anorexia and lower the dose of methylphenidate may be needed to control symptoms.
16
Michael G. Aman, Oscar G. Bukstein, Kenneth D. Gadow et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 2013 · 140 citations · Full text
Medicine, Pediatrics, Psychiatry +17